RNAemia and Severe COVID-19: Candidate Treatment Targets Identified Through Transcriptomics

Clicks: 4
ID: 322920
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #253 of 430 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 430 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Introduction The presence of SARS-CoV-2 RNA in blood has been proposed as a marker of severe COVID-19, but it is unclear whether RNAemia mediates the pathway toward worsening disease. We hypothesized that RNAemia is associated with severe disease and distinct gene expression patterns are associated with RNAemia and severe COVID-19. These RNAemia-associated patterns may identify COVID-19 treatment targets. Methods We analyzed 202 hospitalized COVID-19 participants from a multi-center U.S. Military Health System cohort using digital droplet PCR (ddPCR) to quantify SARS-CoV-2 RNA in plasma and performed host RNA sequencing of peripheral blood. Differential gene expression (DGE) logistic regression models were used to assess associations among RNAemia, host gene expression, and disease severity. Results RNAemia was detected in 39.1% of participants and was associated with severe disease (54% vs. 32% in RNAemia-negative participants; p <0.001). In final adjusted models, independent predictors of severity included RNAemia (adjusted Odds Ratio [aOR] range 1.99-2.24, all p ≤ 0.04), as well as host genes ADAMTS2 (aOR = 1.58, p < 0.001), OLAH (aOR = 1.55, p < 0.001), and PCSK9 (aOR = 1.60, p < 0.001). Discussion RNAemia is an independent predictor of COVID-19 severity. However, host gene expression changes associated with RNAemia, particularly involving OLAH, PCSK9, and ADAMTS2, had stronger statistical evidence of severe outcomes than RNAemia itself. PCSK9 is an intervenable treatment target worth further study.
Reference Key
openalex_W7171730982 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sultanah Alharthi, Nusrat J Epsi, David A Lindholm, Pavol Genzor, Milissa Jones, Heba H. Mostafa, Anuradha Ganesan, Rupal Mody, Katrin Mende, Manish Bhomia, Carlos Maldonado, Timothy Burgess, David R. Tribble, Mark P. Simons, Rhonda E Colombo, Stephanie A Richard, Brian K. Agan, Clifton L. Dalgard, J. Stephen Dumler, Simon D Pollett, Paul W. Blair, J Cowden, M Darling, S DeLeon, A Markelz, S Merritt, T Merritt, N Turner, T Wellington, S Bazan, P K Love, N Dimascio-Johnson, N Elnahas, E Ewers, K Gallagher, C Glinn, U Jarral, D Jennings, D Larson, K Reterstoff, A Rutt, A Silva, C West, J Bowman, S Chambers, C Colombo, C Conlon, K Everson, P Faestel, T Ferguson, L Gordon, S Grogan, S Lis, M Martin, C Mount, D Musfeldt, D Odineal, M Perreault, W Robb-McGrath, R Sainato, C Schofield, C Skinner, M Stein, M Switzer, M Timlin, S Wood, S Banks, R Carpenter, L Kim, K Kronmann, T Lalani, T Lee, A Smith, R Smith, R Tant, T Warkentien, C Berjohn, S Cammarata, N Kirkland, D Libraty, R Maves, G Utz, C Bradley, S Chi, R Flanagan, A Fuentes, M Jones, N Leslie, C Lucas, C Madar, K Miyasato, C Uyehara, H Adams, B Agan, L Andronescu, A Austin, B Barton, D Becher, C Broder, C Byrne
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag390
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.